LUND, Sweden, Feb. 12, 2019 /PRNewswire/ --
Immunovia invites to a teleconference (in English) for
investors, analysts and media on February
14, at 5:30 – 6:30 p.m. CET.
Immunovia will publish the company's Full Year Report 2018 for the
period January – December 2018 on
Thursday, February 14, at
5:05 p.m. CET.
Mats Grahn, CEO will present
Immunovia and comment on the Full Year Report 2018 followed by a
Q&A-session. Please call in a few minutes in advance.
To attend, please dial-in at one of the numbers below:
SE: +46850558352
BE: +3226200547
CH: +41225675632
DE: +4969222220380
DK: +4578150109
FR: +33170750721
NL: +31207219495
NO: +4723500236
UK: +443333009035
US: +16467224956
For questions or interview
bookings:
ir@immunovia.com
There will be an MP3-file available at Immunovia's webpage under
Investors/audio-galley
(https://immunovia.com/investors/audio-gallery/) for those who want
to listen to the telephone conference afterwards. The file will be
available within two hours after the conference has ended.
About Immunovia
Immunovia AB was founded in 2007 by investigators from the
Department of Immunotechnology at Lund University and CREATE Health, the Center
for Translational Cancer Research in Lund, Sweden. Immunovia's strategy is to
decipher the wealth of information in blood and translate it into
clinically useful tools to diagnose complex diseases such as
cancer, earlier and more accurately than previously possible.
Immunovia´s core technology platform, IMMray™, is based on antibody
biomarker microarray analysis. The company is now performing
clinical validation studies for the commercialization of IMMray™
PanCan-d that could be the first blood based test for early
diagnosis of pancreatic cancer. In the beginning of 2016, the
company started a program focused on autoimmune diseases
diagnosis, prognosis and therapy monitoring.
(Source: www.immunovia.com)
Immunovia's shares (IMMNOV) are listed on Nasdaq Stockholm. For
more information, please visit www.immunovia.com.
This information was brought to you by Cision
http://news.cision.com
http://news.cision.com/immunovia-ab/r/invitation-to-presentation-of-immunovia-s-full-year-report-2018-on-february-14--2019,c2739332
The following files are available for download:
https://mb.cision.com/Main/13121/2739332/989764.pdf
|
Immunovia, PR
Telconference Q4
|
View original
content:http://www.prnewswire.com/news-releases/invitation-to-presentation-of-immunovias-full-year-report-2018-on-february-14-2019-300794090.html
SOURCE Immunovia AB